unusual cross-sectional imaging features such as large meningeal cysts and ring enhancement can be misleading. Atypical imaging features are important to recognize, to ensure that meningiomas are included in the differential diagnosis. 34 Meningiomas account for fewer than 5% of pediatric brain tumors, with a reported slight male predominance. 17, 38 When encountered in children, there is an increased association with neurofibromatosis Type 2 (NF2) or prior radiation therapy for neoplasia. 32 However, less commonly, sporadic meningiomas also occur in children, and they may exhibit atypical imaging features because they can arise in unusual locations, where they appear to be associated with a higher pathological grade. 26 Sporadic meningiomas in adults show different molecular features that correlate with location, suggesting the possibility that different mechanisms may be driving pathogenesis. 6 Furthermore, it has been suggested that sporadic meningiomas in adults and children represent very different disease processes, as is the case with other primary brain tumors. 2, 44 A number of studies characterizing NF2-associated and radiation-induced pediatric meningiomas have been published, but the radiological and pathological features of sporadic pediatric meningiomas are poorly characterized and limited to a few case reports. 19, 28, 30 To address this, we examined all meningioma cases at our institution by performing a retrospective radiological and pathological review, and a correlation with literature review. We hypothesize that sporadic pediatric meningiomas arising in atypical locations based on imaging may predict a higher histopathological grade.
Methods

Patient Selection
A retrospective review was approved by our institutional review board. The analysis was performed in individuals who were admitted from January 1, 1989, to January 1, 2013. Hospital records were retrieved according to coding from the ICD-9. We searched records that included the ICD-9 codes 225.2 (meningioma). Patients with meningiomas associated with NF2 and those occurring after CNS radiation therapy for malignancy were excluded. Clinical records were also reviewed for demographic data.
Imaging Modalities and Findings
Images of the sporadic meningiomas were reviewed by pediatric neuroradiologists (J.A.R., C.P.P.). The neuroradiologists were blinded to the original radiology report and reached independent conclusions following analyses of each tumor. Any discrepancies in the interpretation were then resolved by consensus.
Radiography, CT, and MRI studies were reviewed. Brain CT scans were performed on a GE scanner (8-slice Ultralightspeed or 16-slice VCT scanner). Optiray 240 (Mallinckrodt, Inc.) was the primary CT intravenous contrast agent used at our institution during the study period. All MRI scans were performed on 1.5-or 3-T GE magnets (Signa Genesis, Excite, or HDxt; GE Medical Systems), and gadopentetate dimeglumine (Magnevist; Bayer HealthCare Pharmaceuticals, Inc.) was the only MRI contrast agent used. The most common MRI brain sequences performed were precontrast sagittal and axial T1-weighted; axial proton density and T2-weighted fast spin echo; axial diffusion-and susceptibility-weighted; and postcontrast axial T1-weighted and coronal T2-weighted FLAIR. The MRI cervical spine sequences performed were precontrast sagittal and axial T1-and T2-weighted, and postcontrast sagittal and axial T1-weighted. All patients underwent at least one CT or MRI study prior to resection.
Recorded imaging findings included tumor location, size (volume in milliliters), enhancement, adjacent edema, presence of a dural tail, and malignant features (restricted diffusion or rapid growth) for each tumor by consensus. Tumor volume was calculated by multiplying the anteroposterior, craniocaudal, and transverse dimensions of the lesion by 0.52, for the volume of a prolate ellipse.
Typical meningiomas were classified by the following characteristics: CT demonstrating common diagnostic features including a sharply circumscribed solitary mass with a broad-based dural attachment and occasionally thickening and sclerosis of the adjacent calvaria. On noncontrast CT, the mass appears as an area of homogeneous hyperattenuation; after the administration of intravenous contrast, the mass homogeneously enhances. 33 The MRI features include a well-circumscribed, solitary, dural-based mass with a dural tail and inward displacement of the adjacent cortex. 49 On noncontrast MRI, meningiomas are typically hypointense to isointense with T1-weighted pulse sequences, and isointense to hyperintense with T2-weighted pulse sequences. On postcontrast MRI, meningiomas enhance homogeneously. 49 Surrounding vasogenic edema, internal calcifications, and thickening or scalloping of the adjacent calvaria are variably seen.
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Pathological Findings
All slides of histopathological specimens for all sporadic meningiomas were retrospectively reviewed by 2 neuropathologists (C.R.P., D.R.B.). Findings, including WHO subclassification and grade, were recorded for each tumor independently, and discrepancies were resolved by consensus. 29 All related pathology reports were also reviewed (D.R.B.) to confirm a complete correlation with the original review's diagnosis of the pathology materials.
For each specimen successfully cultured for karyotypic analysis, 2 karyotypes and metaphase spreads from each clone and/or case were prepared with the data processing methods by the Cytogenetics Laboratory at The Ohio State University. At central karyotype review sessions, every karyotype and metaphase spread was reviewed by 2 cytogeneticists. In some cases, usually those with more complex chromosome abnormalities and/or with suboptimal banding quality, other reviewers also rendered an opinion. Once consensus was reached, each submission was judged as either acceptable with adequate banding quality, acceptable with borderline banding quality, or inadequate and consequently rejected. Reasons for rejection included poor banding quality that made unequivocal karyotype interpretation impossible and, only in cases with a normal karyotype, analysis of < 20 metaphase cells.
Results
Forty-six meningiomas underwent either biopsy or resection at our institution between 1989 and 2013. Meningiomas associated with NF2 (6 children) and radiation therapy (16 adults, 9 children) were excluded, resulting in the remaining 15 pediatric sporadic meningiomas, accounting for 1.7% of pediatric brain tumors at our institution during the study period (Table 1) .
Imaging Groups
The 15 meningiomas were divided into 2 imaging groups based on tumor location, and were designated as typical and atypical. Typical meningiomas were dural based, and atypical tumors were intraparenchymal, intraventricular, or intraosseous based on imaging findings alone. Five (33%) tumors were radiographically typical and 10 (67%) were radiographically atypical. Typical meningiomas occurred in 4 females and 1 male, ages 1-16 years (mean 11 years). Four (80%) of these lesions were intracranial; 1 (20%) was in the cervical spine. The tumors ranged in volume from 4 to 116 ml (mean 29 ml). All typical tumors showed CT and/or MR contrast enhancement (5/5, 100%) and most had adjacent edema (4/5, 80%) and/ or a dural tail (4/5, 80%). No restricted diffusion or rapid growth was seen in the 3 typical tumors that had diffusionweighted imaging (Table 2 , Fig. 1A-D) .
The 10 atypical meningiomas were seen in 5 female and 5 male patients with a similar age range of 7-21 years (mean 10 years). Half of these tumors appeared to be intraaxial rather than dural based, and were classified as intraparenchymal (5/10, 50%). Three tumors (30%) were intraosseous, 1 (10%) was intraventricular, and 1 was fissural (10%). Atypical tumor volume ranged from 1 to 35 ml (mean 16 ml). Most of these tumors enhanced after contrast administration (8/10, 80%), a small percentage showed adjacent edema (3/10, 30%), and rarely was there a dural tail (1/10, 10%). One of the intraparenchymal tumors showed restricted diffusion and rapid growth. All sporadic meningiomas, regardless of location, showed relatively well-circumscribed borders without radiologically infiltrative margins (Table 2, Fig. 1E-H) .
Pathological Findings
Four (80%) of the typical tumors were classified as WHO Grade I, with the other one classified as WHO Grade II (clear cell histopathology). None of the radiographically typical tumors had malignant features, meaning that no anaplastic cytological features or abnormally increased mitoses were observed. Brain invasion and necrosis are more common in malignant meningiomas, but these features alone are insufficient to define a meningioma as high grade (Tables 1 and 2 , Fig. 1A-D) .
Most of the radiographically atypical tumors (6/10, 60%) were classified as WHO Grade II or III. Intraparenchymal tumors were classified as WHO Grade II (transitional [1] , chordoid [2] ) or WHO Grade III (papillary [1] , rhabdoid/anaplastic [1] ) pathology (Table 1) . One intraparenchymal atypical meningioma with Grade II chordoid histopathological findings demonstrated rapid growth over a 3-month period ( Fig. 1G and H) . At gross and histopathological evaluation, 3 of the 5 intraparenchymal meningiomas, which appeared to have no dural tail at imaging, were ultimately found to have dural attachments on pathological evaluation. Tumor cells grew for karyotype analysis from 3 intraparenchymal meningiomas. These tumors had abnormal karyotypes involving chromosome 22, and included 2 WHO Grade II (both chordoid) atypically located meningiomas and one WHO Grade III (papillary) atypically located meningioma.
There were 3 intraosseous tumors (1 WHO Grade II and 2 WHO Grade I), of which 2 showed transitional histopathological features; all 3 of these meningiomas were seen in female patients (Fig. 1I and J) . Both the intraventricular and fissural radiographically atypical meningiomas showed WHO Grade I pathology.
Discussion
There is significant literature on the unique pathological features of meningiomas associated with NF2 and prior radiation, which often have a higher pathological grade. 10, 20, 28 There are fewer publications regarding pediatric sporadic meningiomas. Most articles are in the form of case reports or small series in which sporadic tumors and their pathology were not specifically evaluated.
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The purpose of our retrospective study of 15 pediatric sporadic meningiomas collected over 24 years was to determine if sporadic pediatric meningiomas with atypical radiological features would be of a higher pathological grade. Tumors were considered typical if they appeared to be dural based and atypical if they were intraparenchymal, intraventricular, or intraosseous. Even though this is the largest series of its kind, the number of cases is still relatively limited; however, in our experience most of the atypically located tumors were WHO Grade II or III, whereas tumors arising in more typical locations were primarily WHO Grade I or II.
In particular, our study had a fairly large number of intraparenchymal meningiomas, the largest number in a single study. In previous meta-analyses, 80%-90% of meningiomas are Grade I, whereas 5%-15% are Grade II, and 1%-3% are Grade III. 27, 39 Histopathologically, the meningothelial subtype is the most common (54.3%), whereas the fibrous subtype accounts for 17.2%. 27 Interestingly, in a recent review of intraparenchymal meningiomas, 28% of the pediatric cases were Grade II-III 26 (Table 3) . 31 In one review of meningiomas in children and adolescents, 78.9% were WHO Grade I, 9.9% were Grade II, and 8.9% were Grade III. 17 Recent large genetic analyses of meningiomas have demonstrated mutations in a number of genes other than the prototypical Neurofibromin 2 mutation on chromosome 22, which is found in most WHO Grade I tumors. 4, 6 Interestingly, in our small series, the 3 tumors with successfully obtained karyotypes showed involvement of chromosome 22, these tumors were primarily WHO Grade II-III, were all atypical in location, and were all intraparenchymal lesions (Table 1) . These recently characterized mutations are believed to alter specific signaling pathways and suggest that meningiomas can arise via different molecular mechanisms and that they may play a role in WHO Grade II and III lesions. Studies show that skull base and ventral meningiomas manifest distinct genetic alterations, indicating that meningiomas differ biologically based on location. However, none of these studies included pediatric patients, so these data may only reflect the genetics of adult meningiomas. It is very likely that meningiomas in adult and pediatric patients arise by different mechanisms, because the clinical setting is markedly different.
2 Therefore, applying molecular analyses in pediatric meningiomas may help elucidate potential biological differences between sporadic pediatric and adult meningiomas to account for the higher rates of invasion and recurrence in the former. Cellular proliferation is not substantially different between pediatric and adult meningiomas, so this alone cannot account for differences in tumor behavior. 1, 36 This further indicates that meningiomas arising in adults and children develop according to different molecular mecha- nisms, are different biologically, and may need to be treated differently. The application of unbiased genetic profiling techniques has demonstrated that other adult and pediatric brain tumors that share similar histopathological features are distinct biological entities at the molecular level, which could very well be the case for meningiomas also. 1, 2, 6, 36 We were interested in testing whether atypical histopathological findings could be predicted based on atypical imaging findings and, in this series, radiologically atypical sporadic meningiomas were more likely to be high grade (60% were WHO Grade II or III). We found radiographically typical meningiomas mostly in girls (4 females and 1 male), but radiographically atypical meningiomas arose in both sexes equally (5 female and 5 male patients). In adults, meningiomas tend to arise in females, in contrast to children, where males reportedly predominate in some studies. 17, 21, 32 More cases will need to be studied to fully elucidate the effect of sex in pediatric patients.
Limitations of our study include the relatively small size of this single-institution cohort, and because our institution is a pediatric brain tumor referral center this may affect the ability to generalize our data. The retrospective design may also be limiting-cases were collected over a period of many years, during which technological advances occurred. For this reason diffusion-and susceptibilityweighted sequences were only performed in a small number of the more recent cases, disallowing comprehensive imaging analysis of these parameters across the entire cohort. Even though this is the largest series of sporadic pediatric meningiomas in atypical locations, caution is warranted due to the limited total number of cases. It is still worth noting, however, that the incidence of meningioma histopathological subtypes seen in this series was higher than would be expected in an adult series.
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Conclusions
This is the largest series of its kind to analyze both intraosseous and intraparenchymal meningiomas among sporadic and familial meningiomas. In a previous metaanalysis of more than 677 meningiomas (including NF1-and NF2-affected patients), there were only 6 intraparenchymal and 1 intraosseous lesion. 17 Therefore, our study represents the most complete investigation to date examining the imaging appearance of typical and atypical meningiomas and their associated pathological features. Sporadic meningiomas are uncommon in children, and most show atypical histopathological features that appear to correlate with a higher WHO pathological grade. Awareness of these distinctions is important for proper patient management. In the future, molecular profiling hopefully will improve our understanding of the apparent biological differences between pediatric and adult meningiomas.
